Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4296137 Target Snapshot

Protein cereblon/BCR/ABL · PROTEIN-PROTEIN INTERACTION · Homo sapiens

100Compounds
67Assays
2Approved Drugs
28.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P00519. Use UniProt P00519 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P00519 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Protein cereblon/BCR/ABL as ChEMBL target CHEMBL4296137, mapped to UniProt P00519. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Protein cereblon/BCR/ABL
PROTEIN-PROTEIN INTERACTION · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4296137
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P00519
Tyrosine-protein kinase ABL1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Protein cereblon/BCR/ABL is the right protein anchor across sources, using UniProt P00519 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelTyrosine-protein kinase ABL1
UniProt AccessionP00519
Component TypeProtein
Sequence Length1130 aa

Tyrosine-protein kinase ABL1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Protein cereblon/BCR/ABL, mapped to UniProt P00519. ChEMBL maps the protein component as Tyrosine-protein kinase ABL1. Sequence length is 1130 aa.

Mapped IDP00519
Review nameProtein cereblon/BCR/ABL
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
Assay Mix

Activity Type Distribution

EC5018.0
KD10.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4748640 9.96 Kd 0.11 Preclinical
CHEMBL4742867 9.89 Kd 0.13 Preclinical
CHEMBL4747034 9.64 Kd 0.23 Preclinical
CHEMBL4642168 9.49 Kd 0.32 Preclinical
CHEMBL4742759 9.26 Kd 0.55 Preclinical
CHEMBL4642168 8.36 EC50 4.4 Preclinical
CHEMBL4208229 8.24 EC50 5.8 Approved
CHEMBL1171837 7.97 EC50 10.6 Approved
CHEMBL4640401 7.54 EC50 28.5 Preclinical
CHEMBL4649252 6.35 EC50 450.0 Preclinical
Distribution

pChEMBL Value Distribution

1
5.0
4
5.5
3
6.0
0
6.5
0
7.0
2
7.5
3
8.0
0
8.5
5
9.0
5
9.5
pChEMBL
Approved Drugs

Approved Drugs

ASCIMINIB
CHEMBL4208229
Approved 2021
PONATINIB
CHEMBL1171837
Approved 2012
Assay Landscape

Assay Landscape

67
Total Assays
17
Tested Compounds
1
Assay Types
Binding — 67 assays, 17 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 65 12 6.7
protein format 2 5 9.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine